Skip to main content

Advertisement

Table 3 Demographics associated with Toxoplasma seropositivity in participants by univariate analysis

From: Toxoplasma gondii infections among pregnant women, children and HIV-seropositive persons in Accra, Ghana

Study participants Number examined (N) Anti-Toxoplasma gondii seropositivity (n/N; %) χ 2 value p value (CI 95 %)
Pregnant women 125 64 (51.2)   
 Age groups     
  16–20 4 4 (100) 3.94 <0.05*
  21–30 57 30 (52.6) 0.08 0.76
  31–40 58 27 (46.6) 0.94 0.33
  41–44 6 3 (50.0) 0.04 0.95
 Stage of pregnancy     
  1st trimester 7 4 (57.1) 0.11 0.74
  2nd trimester 38 22 (57.8) 0.98 0.32
  3rd trimester 80 38 (47.5) 1.21 0.26
Gravida status of women     
 Primigravids 49 17 (34.7) 8.79 0.003*
 Multigravids 76 47 (61.8)   
HIV-seropositive persons 125 72 (57.6)   
 Age groups     
  15–24 4 1 (25.0) 1.79 0.17
  25–34 27 16 (59.3) 0.04 0.84
  35–44 51 26 (50.9) 1.54 0.21
  45–54 30 20 (66.7) 1.32 0.25
  55–64 12 8 (66.7) 0.44 0.50
  65–68 1 1 (100) 0.74 0.389
 Gender     
  Male 54 32 (59.2) 0.10 0.74
  Female 71 40 (56.3)   
 CD4+ T cell count cell/mm3     
  <200 9 6 (66.7) 0.32 0.56
  200 ≥ CD4+ ≤ 500 64 38 (59.4) 0.16 0.68
  >500 52 28 (53.8) 0.52 0.47
Children <5 years of age 200 117 (58.5)   
 Age groups     
  0–6 months 27 6 (22.2) 26.46 <0.001*
  6–12 months 30 9 (30.0) 11.80 <0.001*
  1–3 years 69 48 (69.6) 5.31 0.02*
  3 years > X < 5 years 74 53 (71.6) 7.32 <0.001*
 Gender     
  Male 109 68 (62.4) 1.18 0.27
  Female 91 49 (53.8)   
  1. p value was calculated by Pearson’s chi-square (χ 2) with confidence interval (CI) of 95 % and 1 degree of freedom (df). p values less than 0.05 were considered statistically significant and are indicated in bold fonts (*)